| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/10/2003 | US20030131364 Screening for Alzheimer's disease |
| 07/10/2003 | US20030131363 Controlling the activation of genetic translation, cell proliferation, especially hematopoietic cells; drug screening for compounds which alter the activity of the kinase; thalassemias, sickle cell disease, unstable hemoglobins |
| 07/10/2003 | US20030130827 To generate computationally prescreened secondary libraries |
| 07/10/2003 | US20030130626 Apparatus with weeping tip and method of use |
| 07/10/2003 | US20030130499 Solid phase synthesis by solvent extraction and elution |
| 07/10/2003 | US20030130498 Highly infectious rubella virus DNA constructs and methods of production |
| 07/10/2003 | US20030130497 Detection of respiratory viruses |
| 07/10/2003 | US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction |
| 07/10/2003 | US20030130495 G-protein coupled receptors, signal transduction pathways |
| 07/10/2003 | US20030130494 Mammalian chemokine reagents |
| 07/10/2003 | US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 07/10/2003 | US20030130222 Apoptosis; modulate gene expression; central nervous system disorders; anticancer agents; Aids therapy |
| 07/10/2003 | US20030130221 Induction of tolerance to a therapeutic polypeptide |
| 07/10/2003 | US20030130220 Targeted oligonucleotide conjugates |
| 07/10/2003 | US20030130218 Methods of stimulating phagocytosis |
| 07/10/2003 | US20030130217 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 07/10/2003 | US20030130215 Isolated genomic polynucleotide fragments from chromosome 7 |
| 07/10/2003 | US20030130214 Proteins, compositions, diagnostic and therapeutic uses thereof |
| 07/10/2003 | US20030130187 Porcine adenovirus type 3 genome |
| 07/10/2003 | US20030130184 Using protein from papilloma virus; genetic engineering |
| 07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030130174 Antiinflammatory agents; rheumatic diseases; anticholesterol agents |
| 07/10/2003 | US20030129752 MEKK/JNKK-contingent (mitogen extracellular signal regulated kinases (MEKK), Jun N-terminal kinase) signal transduction pathway; tumor necrosis factor; interleukins |
| 07/10/2003 | US20030129746 Monoclonal antibodies for Hepatitis C virus (HCV) infection |
| 07/10/2003 | US20030129745 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 07/10/2003 | US20030129744 Bvdv virus-like particles |
| 07/10/2003 | US20030129741 Immobilization; solid support for analysis |
| 07/10/2003 | US20030129733 Inactivated genomes of diploid microorganisms which are inducible into haploid forms; drug screening |
| 07/10/2003 | US20030129728 Disrupting genes and mixing with plasmids/DNA vaccine; immunology; gene therapy; aging resistance |
| 07/10/2003 | US20030129727 Nucleic acid encoding 5'-3' exonuclease of bacteriophage RM 378 |
| 07/10/2003 | US20030129726 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 07/10/2003 | US20030129725 Zace1: a human metalloenzyme |
| 07/10/2003 | US20030129723 Derived from Pyrococcus; genetic engineering; improved heat resistance |
| 07/10/2003 | US20030129722 Comprises phospholipid scramblase phosphorylated by protein kinases; antithrombotic agents |
| 07/10/2003 | US20030129721 Isolated from methylomonas encoding 2-keto-3-deoxy-6-phosphogluconate/fructose bisphosphate aldolase; pyrophosphate dependent phosphofructokinases |
| 07/10/2003 | US20030129720 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 07/10/2003 | US20030129718 Amylase variants |
| 07/10/2003 | US20030129716 Control system coupled to shocking chamber, which controls the commutator to automatically contact the first electrode of each cuvette in an order and to provide a potential across the cuvette electrodes when contact is made. |
| 07/10/2003 | US20030129709 In a single reaction, the primer is annealed to the target DNA and extended in an extension/polymerization reaction to produce copies of the target DNA comprising the primer. |
| 07/10/2003 | US20030129708 The amino acid sequence corresponding to positions from 947 to 951 in a wild type carbamoylphosphate synthetase is replaced, and feedback inhibition by uridine 5'-monophosphate in the bacterium is desensitized. |
| 07/10/2003 | US20030129706 Fhm, a novel member of the TNF ligand supergene family |
| 07/10/2003 | US20030129703 Modified dorsal tissue affecting factor and compositions |
| 07/10/2003 | US20030129702 DNA encoding galanin GALR2 receptors and uses thereof |
| 07/10/2003 | US20030129701 Detecting a mutation in the RAR epsilon receptor nucleic acid sequences and detecting a level of the soluble form of the receptors |
| 07/10/2003 | US20030129698 Involved in homo and heterotrimerization or oligomerization |
| 07/10/2003 | US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis |
| 07/10/2003 | US20030129696 Polynucleotides and polypeptides encoding receptors |
| 07/10/2003 | US20030129695 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030129694 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule |
| 07/10/2003 | US20030129693 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030129692 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule |
| 07/10/2003 | US20030129690 Linking a bioactive molecule to a cell expressing certain PRO polypeptides by contacting the cell with a specific PRO polypeptide bound to the molecule |
| 07/10/2003 | US20030129689 Nucleotide sequence that encodes a PRO polypeptide. |
| 07/10/2003 | US20030129688 Heregulin variants |
| 07/10/2003 | US20030129687 Keratinocyte growth factor-2 |
| 07/10/2003 | US20030129686 Novel nucleic acid and polypeptide molecules |
| 07/10/2003 | US20030129678 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 07/10/2003 | US20030129667 Measurement of the altered expression of a marker protein, which is the prion protein PrP-sen |
| 07/10/2003 | US20030129663 Methods and compositions for modulating oxidized ldl transport |
| 07/10/2003 | US20030129659 Machine-based method for managing library information, comprising: storing information about associations between members and assay information, and evaluating the stored information to identify a subset of the individual members |
| 07/10/2003 | US20030129655 Nucleic acids encoding GTPase activating proteins |
| 07/10/2003 | US20030129647 Methods for forming recombined nucleic acids |
| 07/10/2003 | US20030129645 Can be used as models for the development of human therapeutic targets, aid in the identification of therapeutic proteins, and serve as targets for the development of human therapeutic agents that modulate kinase activity |
| 07/10/2003 | US20030129644 Used in gene therapy |
| 07/10/2003 | US20030129641 Detecting a nucleic acid specific to the biospecies by hybridizing oligonucleotide synthesized based on a sequence specific to the biospecies in a DNA sequence corresponding to a ribosomal RNA gene or a cytochrome-related gene |
| 07/10/2003 | US20030129640 Target detection method, reagent and method for detecting SNP of DNA nucleotide sequences |
| 07/10/2003 | US20030129639 GDU, a novel signalling protein |
| 07/10/2003 | US20030129636 Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 07/10/2003 | US20030129635 Polynucleotide comprising the complete aveC ORF of S. avermitilis, that lacks the next complete ORF that is located downstream from the aveC ORF in situ in the S. avermitilis chromosome. |
| 07/10/2003 | US20030129626 Methods, kits and compositions pertaining to the suppression of detectable probe binding to randomly distributed repeat sequences in genomic nucleic acid |
| 07/10/2003 | US20030129624 Methods of preparing amplified nucleic acid molecules |
| 07/10/2003 | US20030129623 SR-BI regulatory sequences and therapeutic assays based on the same |
| 07/10/2003 | US20030129614 Providing a porous support that deactivates a nucleic acid amplification inhibitor and directing a fluid through the porous support to separate out the nucleic acid component |
| 07/10/2003 | US20030129611 Provided on hairpin stem- loop molecular beacon probes that hybridize sufficiently near each other on a subject nucleic acid, e.g. mRNA, to generate an observable interaction; lanthanide chelate luminescent resonance energy transfer |
| 07/10/2003 | US20030129610 New QTL's on chromosomes X, 2, 6 and 7 of pigs |
| 07/10/2003 | US20030129608 Non-alloying core shell nanoparticles |
| 07/10/2003 | US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 07/10/2003 | US20030129605 Immunostimulatory activity of CpG oligonucleotides containing non-ionic methylphosophonate linkages |
| 07/10/2003 | US20030129603 Isolating a collection of polynucleotide sequences corresponding to accessible regions of cellular chromatin |
| 07/10/2003 | US20030129601 Selecting the sequences encoding essential molecules as regulatory nucleotidic sequences and proteins for the survival or the virulence of mycobacterium species |
| 07/10/2003 | US20030129596 Chemical compounds |
| 07/10/2003 | US20030129595 Mutations associated with iron disorders |
| 07/10/2003 | US20030129594 Genes and the physics of the DNA double-helix. formulation of a physics-based gene identification (PBGI) method: ab initio identification of genes in eukaryotic genomes |
| 07/10/2003 | US20030129586 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
| 07/10/2003 | US20030129585 Detection of human papillomaviruses |
| 07/10/2003 | US20030129584 Evaluation of biological agents in living target cells |
| 07/10/2003 | US20030129582 Method for determining early HCV seroconversion |
| 07/10/2003 | US20030129264 Tagetes erecta marigolds with altered carotenoid compositions and ratios |
| 07/10/2003 | US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier |
| 07/10/2003 | US20030129243 Transfection of nucleic acid into a cell and/or organ |
| 07/10/2003 | US20030129203 Rep proteins; fusion proteins; high throughput assay; gene therapy |
| 07/10/2003 | US20030129202 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof |
| 07/10/2003 | US20030129201 Methods of preventing and treating flavivirus infection in animals |
| 07/10/2003 | US20030129197 Influenza vaccine |
| 07/10/2003 | US20030129185 Chimeric antibodies; lymphocytes; genetic engineering; for treatment of myeloma |
| 07/10/2003 | US20030129184 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 07/10/2003 | US20030129176 Atherosclerosis-associated genes |
| 07/10/2003 | US20030129175 Gene therapy; heterogeneity tissue transcription; antitumor agents |
| 07/10/2003 | US20030129172 Animal growth regulator |
| 07/10/2003 | US20030129171 Cloning mastitis gene; muscular disorders |